{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:49:20Z","timestamp":1777621760987,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA217685"],"award-info":[{"award-number":["CA217685"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["NIH-NCIK07-CA201013"],"award-info":[{"award-number":["NIH-NCIK07-CA201013"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32 CA101642"],"award-info":[{"award-number":["T32 CA101642"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"CPRIT","doi-asserted-by":"crossref","award":["RP160674"],"award-info":[{"award-number":["RP160674"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004917","name":"CPRIT","doi-asserted-by":"crossref","award":["SAC150061"],"award-info":[{"award-number":["SAC150061"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1136\/ijgc-2022-004100","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T06:05:54Z","timestamp":1678946754000},"page":"749-754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Secondary validation of an ovarian cancer-specific comorbidity index in a US population"],"prefix":"10.1016","volume":"33","author":[{"given":"Chelsey","family":"Vranes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette Calundann","family":"Noer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangshuang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte C","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9273-1115","authenticated-orcid":false,"given":"Ross","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro T","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus Kim","family":"H\u00f8gdall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon H","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2687-7463","authenticated-orcid":false,"given":"Larissa A","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2022-004100_bb0010","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jamcollsurg.2012.06.017","article-title":"Optimal preoperative assessment of the geriatric surgical patient: a best practices guideline from the American College of Surgeons National Surgical Quality Improvement Program and the American Geriatrics Society","volume":"215","author":"Chow","year":"2012","journal-title":"J Am Coll Surg"},{"key":"10.1136\/ijgc-2022-004100_bb0015","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","article-title":"Ovarian cancer","volume":"374","author":"Hennessy","year":"2009","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2022-004100_bb0020","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1200\/JCO.2016.68.6907","article-title":"Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology clinical practice guideline","volume":"34","author":"Wright","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2022-004100_bb0025","doi-asserted-by":"crossref","first-page":"11720","DOI":"10.1038\/srep11720","article-title":"Comorbidity and survival among women with ovarian cancer: evidence from prospective studies","volume":"5","author":"Jiao","year":"2015","journal-title":"Sci Rep"},{"key":"10.1136\/ijgc-2022-004100_bb0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/107327480701400103","article-title":"Interaction between comorbidity and cancer","volume":"14","author":"Extermann","year":"2007","journal-title":"Cancer Control"},{"key":"10.1136\/ijgc-2022-004100_bb0035","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jclinepi.2012.02.017","article-title":"Review of methods used to measure comorbidity in cancer populations: no gold standard exists","volume":"65","author":"Sarfati","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"10.1136\/ijgc-2022-004100_bb0040","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1136\/ijgc-2022-004100_bb0045","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.annepidem.2007.03.011","article-title":"A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients","volume":"17","author":"Klabunde","year":"2007","journal-title":"Ann Epidemiol"},{"key":"10.1136\/ijgc-2022-004100_bb0050","author":"NIH, National Cancer Institute","year":"2021","journal-title":"History of the NCI comorbidity index"},{"key":"10.1136\/ijgc-2022-004100_bb0055","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/00005537-199711000-00009","article-title":"Validation of the Charlson comorbidity index in patients with head and neck cancer: a multi-institutional study","volume":"107","author":"Singh","year":"1997","journal-title":"Laryngoscope"},{"key":"10.1136\/ijgc-2022-004100_bb0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1010-7940(02)00721-2","article-title":"Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer","volume":"23","author":"Birim","year":"2003","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1136\/ijgc-2022-004100_bb0065","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s00264-015-2810-y","article-title":"Validation of the Charlson comorbidity index in patients undergoing revision total hip arthroplasty","volume":"39","author":"Schmolders","year":"2015","journal-title":"Int Orthop"},{"key":"10.1136\/ijgc-2022-004100_bb0070","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/heartjnl-2013-304588","article-title":"Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002\u20132012","volume":"100","author":"Radovanovic","year":"2014","journal-title":"Heart"},{"key":"10.1136\/ijgc-2022-004100_bb0075","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1136\/ijgc-2022-004100_bb0080","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0895-4356(93)90103-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives","volume":"46","author":"Romano","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1136\/ijgc-2022-004100_bb0085","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","article-title":"Development of a comorbidity index using physician claims data","volume":"53","author":"Klabunde","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1136\/ijgc-2022-004100_bb0090","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1136\/ijgc-2022-004100_bb0095","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ygyno.2016.03.034","article-title":"A new clinically applicable age-specific comorbidity index for preoperative risk assessment of ovarian cancer patients","volume":"141","author":"Noer","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-004100_bb0100","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program . SEER*Stat database: incidence - SEER 18 regs custom data. n.d.Available: www.seer.cancer.gov"},{"key":"10.1136\/ijgc-2022-004100_bb0105","author":"National Institutes of Health (NIH)","year":"2021","journal-title":"SEER-Medicare: comorbidity SAS macros"},{"key":"10.1136\/ijgc-2022-004100_bb0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2147\/CLEP.S47150","article-title":"The impact of comorbidity on cancer survival: a review","volume":"5","author":"S\u00f8gaard","year":"2013","journal-title":"Clin Epidemiol"},{"key":"10.1136\/ijgc-2022-004100_bb0115","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41571-019-0167-7","article-title":"Real-world data: towards achieving the achievable in cancer care","volume":"16","author":"Booth","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1136\/ijgc-2022-004100_bb0120","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jclinepi.2022.03.022","article-title":"The Charlson Comorbidity Index: problems with use in epidemiological research","volume":"148","author":"Drosdowsky","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"10.1136\/ijgc-2022-004100_bb0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ygyno.2020.10.027","article-title":"Possible candidate population for neoadjuvant chemotherapy in women with advanced ovarian cancer","volume":"160","author":"Matsuo","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-004100_bb0130","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ygyno.2016.09.002","article-title":"Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States","volume":"143","author":"Melamed","year":"2016","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24024101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24024101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2022-004100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:42:03Z","timestamp":1753224123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24024101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1048891X24024101"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2022-004100","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary validation of an ovarian cancer-specific comorbidity index in a US population","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2022-004100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}